Patents by Inventor Sheila Mac Neil

Sheila Mac Neil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
    Patent number: 6713268
    Abstract: Methods to identify agents having ocular hypotensive activity which have reduced or absent ability to stimulate iridial hyperpigmentation are disclosed. The methods reside in part in detecting the ability of a test compound to interact with the FP receptor.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: March 30, 2004
    Assignee: Allergan, Inc.
    Inventors: David F. Woodward, Licheng Shi, Achim H-P Krauss, Clayton S. Spada, Sheila Mac Neil, Linda C. Smith-Thomas
  • Glaucoma treatments with reduced hyperpigmentation
    Publication number: 20030018078
    Abstract: Methods to identify agents having ocular hypotensive activity which have reduced or absent ability to stimulate iridial hyperpigmentation are disclosed. The methods reside in part in detecting the ability of a test compound to interact with the FP receptor.
    Type: Application
    Filed: June 26, 2001
    Publication date: January 23, 2003
    Applicant: Allergan Sales, Inc.
    Inventors: David F. Woodward, Licheng Shi, Achim H-P Krauss, Clayton S. Spada, Sheila Mac Neil, Linda C. Smith-Thomas